Topal, E. Et Al. 2023. Evaluation of Nephrotoxicity of Extended Lu177-PSMA in Patients with Metastatic Castration-Resistant Prostate Cancer. European Association of Nuclear Medicine Congress , (Vienna, Austria), 151-152.

Topal, E., Kovan, B., Has Şimşek, D., Şanlı, M. Ö., Başaran, M., & Şanlı, Y., (2023). Evaluation of Nephrotoxicity of Extended Lu177-PSMA in Patients with Metastatic Castration-Resistant Prostate Cancer . European Association of Nuclear Medicine Congress (pp.151-152). Vienna, Austria

Topal, Edanur Et Al. "Evaluation of Nephrotoxicity of Extended Lu177-PSMA in Patients with Metastatic Castration-Resistant Prostate Cancer," European Association of Nuclear Medicine Congress, Vienna, Austria, 2023

Topal, Edanur Et Al. "Evaluation of Nephrotoxicity of Extended Lu177-PSMA in Patients with Metastatic Castration-Resistant Prostate Cancer." European Association of Nuclear Medicine Congress , Vienna, Austria, pp.151-152, 2023

Topal, E. Et Al. (2023) . "Evaluation of Nephrotoxicity of Extended Lu177-PSMA in Patients with Metastatic Castration-Resistant Prostate Cancer." European Association of Nuclear Medicine Congress , Vienna, Austria, pp.151-152.

@conferencepaper{conferencepaper, author={Edanur TOPAL Et Al. }, title={Evaluation of Nephrotoxicity of Extended Lu177-PSMA in Patients with Metastatic Castration-Resistant Prostate Cancer}, congress name={European Association of Nuclear Medicine Congress}, city={Vienna}, country={Austria}, year={2023}, pages={151-152} }